CSL HY profit at $US1b-plus for first time
MELBOURNE: Vaccines and blood products supplier CSL’s half-year net profit has surpassed $US1 billion for
MELBOURNE: Vaccines and blood products supplier CSL’s half-year net profit has surpassed $US1 billion for
FEATURED
Special research team creates ‘predictive medicine’ AI tool
Gen Z fear they will be poorest generation
New development earmarked for hospitality and multigenerational living
Public notification opens for 25-unit project on former landfill
Nine-story homeless tower rejected by council in shock vote
Multigenerational affordable housing planned for regeneration site
INNOVATION
